
Cyclin E1 - Wikipedia
G1/S-specific cyclin-E1 is a protein that in humans is encoded by the CCNE1 gene. [5] The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK.
CCNE1 amplification is synthetic lethal with PKMYT1 kinase …
Apr 20, 2022 · To uncover therapeutic targets for tumours with CCNE1 amplification, we undertook genome-scale CRISPR–Cas9-based synthetic lethality screens in cellular models of CCNE1 amplification.
CCNE1 Gene - GeneCards | CCNE1 Protein | CCNE1 Antibody
Dec 24, 2024 · CCNE1 (Cyclin E1) is a Protein Coding gene. Diseases associated with CCNE1 include Pancreatic Cancer and Ovarian Cancer. Among its related pathways are Regulation of activated PAK-2p34 by proteasome mediated degradation and Defective binding of RB1 mutants to E2F1, (E2F2, E2F3).
CCNE1 copy number is a biomarker for response to ... - Cell Press
These studies demonstrate that CCNE1 CN is a clinically tractable biomarker predicting responsiveness to low-dose WEE1i-ATRi for aggressive subsets of OVCAs/EMCAs. Gynecological cancers can be heterogeneous in anatomic location, histology, and genomics.
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy ...
May 5, 2020 · Here, we review the current understanding of one of the most common genetic alterations in epithelial ovarian cancer, CCNE1 (cyclin E1) amplification, and its role as a potential predictive marker of cytotoxic chemotherapy resistance.
Prognostic Values of CCNE1 Amplification and Overexpression in …
A number of studies revealed that CCNE1 copy number amplification and overexpression (on mRNA or protein expression level) were associated with prognosis of diverse cancers, however, the results were inconsistent among studies.
CCNE1 is a predictive and immunotherapeutic indicator in various ...
Mar 24, 2023 · Our study demonstrated that CCNE1 is upregulated in multiple cancers in the TCGA database and may be a promising predictive biomarker for the immunotherapy response in some types of cancers. Moreover, CCNE1 knockdown can suppress the proliferation, migration and invasion of UCEC cells.
898 - Gene ResultCCNE1 cyclin E1 [ (human)] - National Center for ...
Feb 9, 2025 · CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma. Cyclin E1 expression and malignancy in meningiomas. Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells.
CCNE1 cyclin E1 [Homo sapiens (human)] - Gene - NCBI
Feb 9, 2025 · Title: PKMYT1: A Potential Target for CCNE1 Amplificated Colorectal Tumors. Long noncoding RNA LINC02568 sequesters microRNA-874-3p to facilitate malignancy in breast cancer cells via cyclin E1 overexpression.
Molecular landscape and clinical implication of CCNE1-amplified ...
Jan 24, 2023 · Background: Cyclin E1 (CCNE1) amplification (CCNE1 Amp) drives chromosomal instability (CIN) and is associated with immune cell exclusion, liver metastasis, therapeutic resistance, and poor survival in gastric adenocarcinoma (GA).